Cargando…

Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus

BACKGROUND: For young borderline ovarian tumor (BOT) patients, preservation of the uterus was incorporated as an accepted option into treatment guidelines. For the endometrioid subtype (eBOT) however, adequate histological evaluation is challenging and might be associated with synchronous endometria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reichenbach, Juliane, Schmoeckel, Elisa, Mahner, Sven, Trillsch, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265084/ https://www.ncbi.nlm.nih.gov/pubmed/34233728 http://dx.doi.org/10.1186/s13048-021-00839-4

Ejemplares similares

Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)
por: Trillsch, Fabian, et al.
Publicado: (2013)

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study
por: Trillsch, F, et al.
Publicado: (2015)

The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age
por: Della Corte, Luigi, et al.
Publicado: (2022)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
por: Zhang, Wen, et al.
Publicado: (2018)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component
por: Hammouda, Seifeddine Ben, et al.
Publicado: (2022)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

Four cases of endometrioid borderline ovarian tumour: case reports and literature review
por: Nakagawa, Eriko, et al.
Publicado: (2017)

Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
por: Chen, Rui-fang, et al.
Publicado: (2016)

Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland
por: Kipp, B., et al.
Publicado: (2023)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
por: Czogalla, Bastian, et al.
Publicado: (2019)

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Requirement for expert histopathological assessment of ovarian cancer and borderline tumours
por: Sengupta, P S, et al.
Publicado: (2000)

Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
por: Trillsch, Fabian, et al.
Publicado: (2023)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

Extragonadal Giant Endometrial Cyst with Endometrioid Borderline Tumor
por: Yazawa, Hiroyuki, et al.
Publicado: (2019)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021)

Histopathological Patterns of Microinvasion in Ovarian Serous Borderline Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Histopathology and indicators of borderline ovarian tumours with microinvasion in bitches
por: Makovicky, Peter, et al.
Publicado: (2023)

Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome
por: Vasquez, Liliana, et al.
Publicado: (2015)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Dedifferentiated Endometrioid Adenocarcinoma of the Uterus: Highly Aggressive and Poor Prognostic Tumor
por: Park, Shin Young, et al.
Publicado: (2014)

Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature
por: Han, Jiheun, et al.
Publicado: (2017)

Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
por: Goh, C., et al.
Publicado: (2020)

Developing bots with Microsoft bots framework: create intelligent bots using MS bot framework and azure cognitive services
por: Machiraju, Srikanth, et al.
Publicado: (2017)

Developing bots with Microsoft Bots Framework: create intelligent bots using MS Bot Framework and Azure Cognitive Services
por: Machiraju, Srikanth, et al.
Publicado: (2018)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tnlokft0i50klslofrtc3kmfhs